News for: 6 january 2022 in category:
An experimental drug for the treatment of hepatitis C, miravirsen, is able to transfer hepatitis from the list of fatal to chronic. This is evidenced by the results of clinical trials..
Testing has shown that miravirsen suppresses the ability of the hepa...
Health
06 January 2022, 10:08 ()